There are no significant Insider Shareholders in Biomarin Pharmaceutical as of December 12, 2025.
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Jean Jacques Bienaime | 473,892 | 21 May, 2024 | |
| Henry J Fuchs | President And Worldwide R&D | 185,074 | 17 Sep, 2024 |
| Alexander Hardy | Chief Executive Officer | 159,388 | 02 Dec, 2025 |
| Richard A Meier | 127,426 | 22 May, 2025 | |
| Brian Mueller | EVP And Chief Financial Officer | 99,781 | 18 Mar, 2025 |
| Elaine J Heron | 97,720 | 04 Jun, 2024 | |
| George Eric Davis | EVP And Chief Legal Officer | 82,915 | 18 Mar, 2025 |
| Charles Greg Guyer | EVP And Chief Technical Officer | 80,838 | 18 Mar, 2025 |
| Jeffrey Robert Ajer | EVP And Chief Commercial Officer | 66,767 | 06 May, 2024 |
| David E I Pyott | 49,750 | 23 May, 2024 | |
| Gregory R Friberg | EVP And Chief R&D Officer | 43,506 | 02 Oct, 2025 |
| Michael G Grey | 42,840 | 09 Mar, 2021 | |
| Robert J. Hombach | 41,870 | 22 May, 2025 | |
| Willard H Dere | 38,950 | 22 May, 2025 | |
| Elizabeth M Anderson | 34,450 | 22 May, 2025 | |
| V Bryan Lawlis | 33,140 | 24 May, 2023 | |
| Dennis Slamon | 31,299 | 20 Mar, 2024 | |
| Cristin Hubbard | EVP And Chief Commercial Officer | 30,545 | 22 May, 2025 |
| Maykin Ho | 28,010 | 22 May, 2025 | |
| Andrea Acosta | GVP And Chief Accounting Officer | 18,136 | 17 Mar, 2021 |
| Mark J Alles | 15,095 | 24 May, 2023 | |
| Erin Burkhart | GVP And Chief Accounting Officer | 14,173 | 20 May, 2025 |
| Barbara W. Bodem | 13,555 | 22 May, 2025 | |
| Athena Countouriotis | 13,550 | 22 May, 2025 | |
| Mark J Enyedy | 13,550 | 22 May, 2025 | |
| Timothy P Walbert | 9,780 | 22 May, 2025 | |
| Ian T Clark | 7,000 | 05 Aug, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 30 Apr, 2025 | Alexander Hardy | Common Stock | A | 375 | $54.14 | 175,958 | D | A |
| 01 Dec, 2025 | Alexander Hardy | Common Stock | D | 16,570 | $55.03 | 159,388 | D | F |
| 30 Sep, 2025 | Gregory R Friberg | Common Stock | D | 3,304 | $54.16 | 43,506 | D | F |
| 30 Sep, 2025 | Gregory R Friberg | - | - | 43,506 | D | |||
| 01 Aug, 2025 | Ian T Clark | - | - | 7,000 | D | |||
| 01 Aug, 2025 | Ian T Clark | Common Stock | A | 7,000 | $0.00 | 7,000 | D | A |
| 20 May, 2025 | Cristin Hubbard | Common Stock | D | 2,155 | $59.93 | 30,545 | D | F |
| 20 May, 2025 | Willard H Dere | - | - | 38,950 | D | |||
| 20 May, 2025 | Barbara W. Bodem | Common Stock | A | 6,650 | $0.00 | 13,555 | D | A |
| 20 May, 2025 | Mark J Enyedy | Common Stock | A | 6,650 | $0.00 | 13,550 | D | A |
| 20 May, 2025 | Timothy P Walbert | Common Stock | A | 6,650 | $0.00 | 9,780 | D | A |
| 20 May, 2025 | Robert J. Hombach | Common Stock | A | 6,650 | $0.00 | 41,870 | D | A |
| 20 May, 2025 | Maykin Ho | Common Stock | A | 6,650 | $0.00 | 28,010 | D | A |
| 20 May, 2025 | Elizabeth M Anderson | Common Stock | A | 6,650 | $0.00 | 34,450 | D | A |
| 20 May, 2025 | Willard H Dere | Common Stock | A | 6,650 | $0.00 | 38,950 | D | A |
| 20 May, 2025 | Richard A Meier | Common Stock | A | 6,650 | $0.00 | 127,426 | D | A |
| 20 May, 2025 | Athena Countouriotis | Common Stock | A | 6,650 | $0.00 | 13,550 | D | A |
| 19 May, 2025 | Erin Burkhart | - | - | 15,959 | D | |||
| 19 May, 2025 | Erin Burkhart | Common Stock | D | 996 | $59.27 | 15,959 | D | F |
| 20 May, 2025 | Erin Burkhart | Common Stock | D | 1,786 | $59.31 | 14,173 | D | S |